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Abstract  1 
Purpose: In this study, we investigate the effects of pulsatile flow and inflow on dynamic 2 
susceptibility-contrast MRI (DSC-MRI) intravascular arterial input function (AIF) measurement in 3 
human brain arteries and measure how they are affected by first-order flow compensation (FC). 4 
Methods: A dual-echo single-shot EPI sequence with alternating FC gradients was used to 5 
acquire DSC-MRI data with electrocardiogram monitoring. The dynamic signal variations 6 
measured inside the middle- (MCA) and internal cerebral arteries (ICA) was associated to the 7 
pulsatile arterial blood velocities measured with a single-slice quantitative flow sequence 8 
throughout the cardiac cycle. 9 
Results: Major inverse correlations between intravascular signal and blood velocity were found 10 
for the standard SS-EPI sequence. FC reduces these correlated variations that contribute to 11 
signal physiological noise. It causes a significant two-fold increase of intravascular SNR in the 12 
MCA and the ICA, (2.3 ± 0.9, P = 0.03) and (2.0 ± 0.9, P = 0.04) respectively; and reduced phase 13 
standard deviation for the ICA (0.72 ± 0.14, P = 0.004). The correction proposed in this work 14 
translates into a quantitative AIF with reduced noise in the ICA. 15 
Conclusion: The physiological noise added by pulsatile flow and inflow for intravascular AIF 16 
measurement in the brain arteries is significantly reduced by FC.  17 
 18 
Key Words: Dynamic susceptibility contrast MRI; flow compensation; blood flow; arterial input 19 
function; brain perfusion  20 
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Manuscript Body  1 
Introduction  2 
Dynamic susceptibility contrast (DSC) can measure the changes in perfusion for brain tumors 3 
and cerebral ischemia.1 This dynamic imaging method measures the signal during contrast agent 4 
(CA) injection. The temporal signal change of each voxel is caused by CA effect on transverse 5 
relaxation (T2∗) of the tissue and is weighted by tissue perfusion. DSC data analysis provides either 6 
a relative or an absolute quantitative perfusion measurement of cerebral blood flow (CBF) and 7 
volume (CBV). Absolute quantitative perfusion in clinical practice is currently limited because of 8 
the methodological complications and the variability of results reported in the literature.2 A cause 9 
for these variations is the error in the measured arterial input function (AIF), i.e. the tissue feeding 10 
artery concentration-time curve used for perfusion quantification.3  11 
Accurate and precise AIF measurement is challenging.4 A first method is to extract the AIF 12 
from the signal inside a major artery. However, the T2∗-weighting for a typical single-echo DSC 13 
sequence is optimized to detect low CA concentrations in tissues. The resulting T2∗ decrease in 14 
major arteries is so important that the signal drops to the noise floor level at peak CA 15 
concentrations. This prevents accurate quantification of CA concentrations from intravascular 16 
blood signal measurement. An alternative method is to measure the AIF from tissues near the 17 
middle cerebral artery (MCA).5 The signal in these tissues remains well above noise and its 18 
changes are related to the AIF by the distant susceptibility effect of intravascular CA. Alternatively, 19 
the signal drop of a first echo with short TE in dual-echo EPI sequences is significant while 20 
remaining above noise therefore enabling the measurement of an AIF. Simulations have shown 21 
that both extra- and intravascular measurements are optimal for AIF selection with dual-echo EPI 22 
sequences.5 23 
The growing interest in multi-echo DSC sequences for correction of CA extravasation provides 24 
an opportunity to choose between extra- and intravascular AIF measurements. An intravascular 25 
measurement has two advantages. First, it is not contaminated by background microcirculation 26 
that is known to broaden the measured extravascular AIF.6 Second, it allows absolute perfusion 27 
quantification with an AIF from the blood signal of the internal carotid artery (ICA), through a partial 28 
volume correction method (PVCM).7 This PVCM extracts the blood signal from the measured 29 
complex signal, which is contaminated by surrounding tissue. Such correction is possible for the 30 
ICA because its orientation and geometry are a good approximation of an infinite cylinder parallel 31 
to the main magnetic field. This condition nulls the tissue signal variations dependence with CA 32 
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inside the artery. An absolute AIF measurement is not feasible in the MCA where the surrounding 1 
tissue signal depends on the CA-induced susceptibility effect outside the vessel with a strong 2 
dependence on the vessel distance, orientation, and geometry. Instead, intravascular signal 3 
measurements in the MCA provide a scaled version of the true AIF.4 Scaled AIF measurements 4 
provide relative perfusion metrics (rCBV, rCBF) that are usually normalized by the white matter 5 
values contralateral to a lesion. 6 
Both these scaled (MCA) and absolute (ICA) intravascular AIF measurements aim at 7 
measuring the signal of flowing blood. However, these measurements are contaminated by signal 8 
temporal variations inside major arteries that are partly caused by inflow and flow effects.8 The 9 
flow effects are caused by the motion of excited spins during the gradients applied between slice 10 
excitation and signal measurement. These blood spins experience an additional phase dispersion 11 
and offset that affect the complex signal.9 Inflow is caused by unexcited spins entering the slice. 12 
Its effects for AIF measurement have been described on the steady-state magnetization of 3D 13 
DCE sequences,10 and for the typical 2D multi-slices sequences used in DSC where the inflow of 14 
fresh spins partially replenishes the slice between each excitation.11 In this work, we extend these 15 
considerations by accounting for the pulsatile inflow between slice excitation and signal 16 
measurement.  17 
The blood velocity in arteries changes during the cardiac cycle, which translates into repeated 18 
variations of the inflow and flow effects. For brain arteries and the typical single-shot EPI (SS-19 
EPI) sequence used in DSC, the pulsatile blood velocity remains approximately constant for the 20 
short duration of the echo train; every point in k-space of the slice is approximately acquired at 21 
this fixed velocity. On the other hand, DSC dynamic frames are sampled during various phases 22 
of the cardiac cycle, and each can be associated with a specific blood velocity. This effect was 23 
shown for a baboon artery where a correlation was found between the signal variations and the 24 
cardiac cycle phases for a single-echo SS-EPI DSC sequence.12 A first-order flow compensation 25 
(FC) in the slice selection direction limited these effects for AIF measurement.12,13 Such a method 26 
is not standard practice and, to our knowledge, an SS-EPI FC scheme generalized to all directions 27 
was not tested for the measurement of AIFs and is not available on clinical scanners.  28 
The effects of pulsatile flow and excitation-to-measurement inflow on intravascular AIF 29 
measurement in human brain arteries are unknown. This study quantifies the correlation between 30 
the blood signal dynamic variations and its pulsatile velocity in the human MCA and ICA for a 31 
dual-echo SS-EPI sequence. These effects are characterized in several regions of the MCA to 32 
identify an ideal location for blood signal measurement. We show that FC extended to all encoding 33 
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directions yields a two-fold increase of blood SNR in major arteries, and translates into the 1 
quantitative AIF measurement in the ICA. 2 
Methods 3 
Acquisition 4 
Imaging was performed on an Ingenia 3.0T scanner with a 32-channel head receiver coil 5 
(Philips Healthcare, Best, Netherlands). Time of flight (TOF) angiography served to position the 6 
slices precisely over the MCA and to measure MCA and ICA segments angulation with respect 7 
to the imaging plane and B0. A high resolution T1-weighted image was acquired for image 8 
registration. A single-slice quantitative flow sequence measured the subject specific pulsatile flow 9 
velocities perpendicular to the arteries for 15 trigger delays in the cardiac cycle. The maximal 10 
quantitative flow velocity in the artery region of interest (ROI) was calculated for each trigger 11 
delay. A custom single-slice 2D single-shot EPI dual gradient echo sequence was designed for 12 
intravascular signal measurements (Fig. 1a). Dynamic signal variations were assessed while 13 
recording the electrocardiogram (ECG) with automatic R-peak detection and acquisition trigger 14 
tagging; the frames were then sorted by ECG trigger delay. Images were acquired with (FC) or 15 
without (non-FC) first-order FC. For FC, gradient waveforms were added to provide gradient first 16 
moment nulling in all encoding directions (frequency encoding (Gf), phase encoding (Gp), and 17 
slice selection (Gs) gradients). To compare the effect of FC during the same dynamic acquisition, 18 
the gradient waveforms were alternated between the FC and the non-FC sequences. FC (odd 19 
frames) and non-FC (even frames) sequences were acquired alternately for 400 frames without 20 
CA injection. Other sequence parameters were as follows: Flip angle = 90°; FOV = 190 x 226 x 5 21 
mm3; acquired/reconstructed spatial resolutions = 3 x 3 x 5 mm3 / 2.8 x 2.8 x 5 mm3; reconstructed 22 
image matrix = 80 x 80; SENSE factor = 2.3; time resolution = 1.5 s; SPIR fat saturation. Our 23 
sequence acquired spatial resolution is consistent with most DSC-MRI experiment, but the 24 
reconstructed spatial resolution is lower. This is caused by a smaller image matrix, and results in 25 
a reduced post-processing time without any loss of information. 26 
Cohort 27 
The study was approved by the institutional ethics committee and written informed consent 28 
was obtained from each subject. Fourteen young volunteers with an average age of 26 ± 6 years 29 
participated in this study (5 women and 9 men). The effect of FC on the final AIF and perfusion 30 
maps was measured in five subjects. To do so, the alternated FC/non-FC sequence was extended 31 
to multi-slice for the ICA measurements and brain coverage during Gd-DO3A-butrol injection 32 
(0.05 mmol/kg) with 180 frames post-injection and a flip angle of 30°. 33 
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Processing 1 
Data analysis was performed with Matlab R2016a (The MathWorks, Natick, MA). A Hessian 2 
based Frangi Vesselness filter14 and a threshold were applied to the TOF sequence to extract the 3 
subject arterial blood mask (Fig. 1b). The DSC slice position for MCA and ICA were overlaid over 4 
the arterial blood mask. The MCA and ICA segments angulation relative to the imaging plane was 5 
computed from 3D lines fitted over each straight portion of the left and right arteries. 6 
Each DSC dynamic frame and slice was associated with its trigger delay, defined as the 7 
difference between its acquisition timestamp and the previous R-peak timestamp corrected for R-8 
R cardiac cycle period variations. The frames naturally cover the whole range of trigger delays 9 
due to the mismatch between the constant TR and the cardiac cycle period. Signal phase near 10 
the ICA was inspected for phase shifts and unwrapped when necessary.15 Arterial ROIs were 11 
drawn manually to select the voxels with highest diastole signal magnitude within the arterial 12 
structure, as hyperintense blood signal is expected for this sequence with slight tissue saturation. 13 
For the MCA, the voxel selection was limited to a single voxel curve following the artery structure. 14 
This curve was split in four ROIs based on the distance along the M1-segment (Fig. 1c). For the 15 
ICA, the four voxel of highest signal magnitude were selected for each artery (Fig. 1d). Signal 16 
magnitude is reported in arbitrary units (a.u.). 17 
Flow effects metrics 18 
Dynamic noise for a ROI signal magnitude and phase is defined as the standard deviation 19 
(SD) of its signal-time course obtained from repeated acquisitions.16 This noise is influenced by 20 
systematic dynamic signal variations such as the inflow and flow effects in vessels, patient motion, 21 
and other physiological variations. Signal to noise ratio (SNR) was computed for signal magnitude 22 
as the ratio of the mean value and the SD. Spearman correlation coefficient was calculated 23 
between blood flow velocities and signal-time courses (CORR). To do so, the arterial blood flow 24 
velocity acquired for 15 trigger delays was linearly interpolated at each trigger delay of the 200 25 
frames from the FC or non-FC SS-EPI. CORR was calculated between these interpolated 26 
velocities and the signal-time courses. The ratio of FC to non-FC SNR (𝑅SNR = SNR𝐹𝐶 SNR𝑁𝐶⁄ ) 27 
and phase SD (𝑅SD = SD𝐹𝐶 SD𝑁𝐶⁄ ) were taken as a measure of changes caused by FC. Paired 28 
(CORR) and unpaired (RSNR, RSD) Student’s t-tests were used to assess whether the changes 29 
caused by FC are statistically significant (P < 0.05). 30 
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Perfusion experiment 1 
AIF concentration curves were computed from the phase of the first echo arterial ROI signal 2 
curve after applying a complex differences PVCM.7 Briefly, AIF quantification requires removing 3 
the surrounding tissue component from the measured signal. With increasing contrast agent 4 
concentration, blood signal follows a spiral-like trajectory in the complex plane caused by 5 
concurrent magnitude decrease (T2∗) and phase change (susceptibility effects); whereas tissue 6 
signal is approximately constant as it is independent of the intravascular contrast agent for the 7 
ICA parallel with the main magnetic field. The PVCM fits a CA calibration curve spiral over the 8 
complex signal of the first pass time frames to find the constant tissue complex signal. The 9 
contribution of surrounding tissue is then removed from the measured signal. The corrected signal 10 
phase changes (Δ𝜃(𝑡)) are related to the arterial concentration (𝐶𝐴(𝑡)) by the equation: 11 
 Δ𝜃(𝑡) =
1
3
𝛾B0𝜒𝑚𝐶𝐴(𝑡) (1) 
with an assumed molar susceptibility of 𝜒𝑚 = 3.209 × 10−7 mol−1.7 The calibration curve 12 
parameters are defined by this molar susceptibility and the quadratic ΔR2,blood∗  relaxation rate for 13 
blood reported at 3T:17 14 
 ΔR2,blood∗ (𝑡) = 𝑟𝐶𝐴(𝑡) + 𝑞(𝐶𝐴(𝑡))
2 (2) 
with 𝑟 = 0.4929 (mM s)−1 and 𝑞 = 2.6159 (mM2 s)−1. 15 
Cerebral tissue concentration (𝐶𝑇(𝑡)) was computed using the ratio of the first echo signal 16 
(𝑆1(𝑡)) over the second echo signal (𝑆2(𝑡)):  17 
 𝐶𝑇(𝑡) =
1
TE2 − TE1
ln [
𝑆1(𝑡)𝑆2(𝑡0)
𝑆2(𝑡)𝑆1(𝑡0)
] /𝑟2
∗ (3) 
where 𝑆1,2(𝑡0) are the mean pre-injection signals of the first and second echoes, assuming a linear 18 
CA relaxivity of 𝑟2∗ = 87 (s ∙ mM)−1.17 The tracer arrival time was measured for each voxel by 19 
computing the intersection between the pre-enhancement concentration and the exponential 20 
function that fits the first pass enhancement slope. CBF was computed by solving the basic tracer 21 
kinetic equation (𝐶𝑇(𝑡) = 𝐶𝐴(𝑡) ⊗ (CBF 𝑅(𝑡))) with deconvolution using Tikhonov’s regularization 22 
and cubic B-spline constraint on a tissue residue function (𝑅(𝑡)).18 CBV was determined from the 23 
ratio of the areas under the tissue and arterial concentration time curves.  24 
Registration of perfusion maps on the high resolution T1-weighted image was performed with 25 
Statistical Parametric Mapping (SPM12, revision number 6685). The gray (GM) and white matter 26 
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(WM) masks were derived from the SPM12 tissue probability maps segmented over a subject’s 1 
high resolution T1-weighted images and linearly interpolated over the perfusion maps. The mask 2 
was limited to the three top brain slices to avoid the signal loss near the prefrontal sinus. Perfusion 3 
values for FC against non-FC were plotted for all voxels of this mask and fitted with a linear 4 
regression (𝑦𝐹𝐶  =  𝑚 ⋅ 𝑥𝑛𝑜𝑛−𝐹𝐶  + 𝑏). The percent deviation of its slope from the line of equality 5 
(𝐷𝐹𝐶 = 100% (𝑚 − 1)) is taken as a measure of global agreement between FC and non-FC. The 6 
SD of DFC was computed from the 95% confidence interval of the fitted slope.  7 
Results 8 
Dynamic variations of blood signal 9 
Slice positioning for intravascular dynamic measurements and evaluation of the vessel shape 10 
were based on TOF data (Fig. 1b). The associated manual ROI selection is shown in the SS-EPI 11 
image of one subject for MCA (Fig. 1c) and ICA (Fig. 1d). 12 
We evaluated whether the blood signal variations in these ROIs were correlated with blood 13 
velocity. The signal-time curves before CA injection are shown in Fig. 2a. Dynamic gradients 14 
waveforms alternation allows to extract both non-FC and FC curves from the same dynamic 15 
acquisition. Increased SNR can already be appreciated from the FC curve. ECG trigger delay was 16 
associated with each dynamic frame during post-processing (Fig. 2c). Sorting signal-time curves 17 
by trigger delay unveils signal variations that have a large inverse correlation with pulsatile blood 18 
velocity (CORR = -0.86, P < 0.001) (Fig. 2b). FC substantially decreases the correlation between 19 
signal and blood velocity (CORR = -0.38, P < 0.001); this translates into a reduction of the 20 
apparent noise in the corresponding curve in Fig. 2a. Non-FC correlation measurements were 21 
highly significant (P < 0.001) for all subjects. The only non-significant correlations (P > 0.05) were 22 
found for FC measurements in the ICA for three subjects. This is expected for these cases since 23 
the correlation was approaching zero (|CORR| < 0.11). The p-value indicates the significance 24 
level of the correlation and could evaluate the effect of FC, but we report only the more intuitive 25 
correlation value for the remaining work.  26 
Examples of the sorted signal curves and their associated flow effect metrics for a 27 
representative individual subject are shown in Figs. 3 and 4 for the MCA and the ICA, respectively. 28 
In Fig. 3, intravascular signal variations are highly correlated with blood velocity for all ROIs. FC 29 
partially eliminates this correlation for ROI 3, which results in a 2.3x increase of SNR. The signal 30 
variations for ROIs 1, 2 and 4 cannot be removed by FC. For this reason, ROI 3 in the MCA was 31 
chosen for further evaluation of the effects of FC. In Fig. 4, ICA magnitude and phase signal 32 
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variations are inversely correlated with blood velocity. FC alleviates most of the correlation 1 
between signal magnitude and velocity, but the effect is limited for the signal phase in this subject. 2 
The statistical differences between FC and non-FC are not reported for these individual subject 3 
data but are reported in the following results for the whole cohort. 4 
The RSNR, RSD, and correlation metrics for MCA ROI 3 and ICA were calculated for every 5 
subject (Fig. 5). FC results in a significant two-fold increase of blood SNR in the MCA and the 6 
ICA, (2.3 ± 0.9, P = 0.03) and (2.0 ± 0.9, P = 0.04) respectively (Fig. 5a); and reduced phase SD 7 
for the ICA (0.72 ± 0.14, P = 0.004) (Fig. 5b). Signal to velocity correlation changes were only 8 
significant for ICA signal magnitude (P = 0.01) and phase (P = 0.002) (Fig. 5c). 9 
Perfusion experiment 10 
We next assessed whether the FC pre-injection noise reduction translates into improved AIF 11 
and perfusion measurements. Images were acquired with the alternated sequence during and 12 
after CA injection. The PVCM corrected phase-based AIF of all subjects are reported in Fig. 6. It 13 
is immediately apparent that data points acquired at peak velocity with the non-FC scheme (open 14 
circles) are an important source of noise. Reduced noise in the FC signal phase (open squares) 15 
translates to the AIF, seven out of ten cases showed reduced sharp temporal variations 16 
associated with noise. The only exceptions are the AIFs of panels g, i and j where FC does not 17 
provide apparent noise reduction. The major AIF non-FC to FC differences of Fig. 6h and j are 18 
caused by variations of the solution of the PVCM. The PVCM is detailed for two AIFs in Fig. 7 for 19 
non-FC and FC acquisitions. For both AIFs, the signal in the complex plane for non-FC data (Fig. 20 
7a,c) appears to be noisier than their FC counterparts (Fig. 7b,d) as judged from the reduced 21 
contrast between the first pass time frames (black dots) and the other time frames (gray dots). 22 
Major differences in the fitted calibration curve for the non-FC and FC AIF of subject 5 (Fig. 7c,d) 23 
result in a truncated AIF peak for the non-FC data and a shift of the concentration values at 85 s 24 
(Fig. 7f). This shift matches major subject motion in the raw dynamic images resulting in the 25 
exclusion of this dataset from perfusion maps measurements. 26 
We examined the effect of FC on perfusion maps. The AIF from the left ICA (Fig. 6f) was 27 
chosen for the perfusion measurement of Fig. 8. Qualitatively comparable CBF and CBV maps 28 
are obtained from FC and non-FC data (Fig. 8ac). The voxel by voxel comparison of Fig. 8b and 29 
8d highlights the global differences between the two sequences. The agreement between FC and 30 
non-FC values are fair and show a slight deviation above and below the line of equality for CBF 31 
and CBV, respectively. Table 1 shows the perfusion results for all subjects AIFs with average 32 
values of CBF and CBV over GM and WM ROIs and the DFC. FC increases the CBF for five cases 33 
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and reduces the CBV for six cases as can be seen by the significant changes highlighted in the 1 
DFC column. The perfusion results from an AIF with major non-FC to FC PVCM differences is 2 
underlined. 3 
Discussion 4 
Dynamic variations of blood signal 5 
Pulsatile constant-velocity flow effects are a major cause of blood signal variations for 6 
intravascular AIF measurement in the MCA. FC fully compensates these effects for the center of 7 
k-space with increasing residual flow effects along the SS-EPI echo train. Overall, pulsatile blood 8 
signal variations in DSC-MRI are partially recovered by FC. This was shown theoretically in the 9 
tube simulation of the supporting information (Fig. S1) and confirmed by the increased SNR in 10 
clinical pre-injection measurements (Fig. 5a). 11 
Strong inverse correlations between MCA and ICA intravascular signal and blood velocity 12 
were found for standard (non-FC) SS-EPI sequence (Fig. 5c). FC reduces the negative correlation 13 
contribution of constant-velocity flow effect; the CORR values become closer to zero. The 14 
correlation of blood signal with blood velocity causes random fluctuations in the non-FC signal-15 
time course. Compensating for flow effects yields a significant two-fold increase of SNR and a 16 
significant decrease of phase SD for the ICA (Fig. 5ab). As FC corrects only for constant-velocity 17 
flow effects, it shows that these effects are a major source of dynamic noise for intravascular AIF 18 
measurement. A weaker inverse correlation is found for the ICA signal phase than for the signal 19 
magnitude (Fig. 5c). Signal phase variations have been linked to the respiratory cycle by others,12 20 
and could explain increased uncorrelated noise sources in phase data. Similar results for the FC 21 
effects on pre-injection intravascular signal are reported for the perfusion sequence with a 30° flip 22 
angle (Supporting information - Fig. S2). 23 
Other sources of velocity-correlated signal variations could not be recovered by FC, i.e. inflow 24 
and higher order flow effects. The methods in this work were developed to reduce these effects. 25 
First, careful slice placement is required to limit unexcited blood inflow for the in-slice MCA AIF. 26 
The MCA has an approximate diameter of 3 mm in this region, which allows margins for blood 27 
excitation with the 5 mm slice of the SS-EPI sequence while minimizing tissue signal in the voxel 28 
volume. During sequence planning, the 5 mm slice was positioned to cover both left and right 29 
MCA M1-segment on the TOF images. Arterial masks show good slice placements for most of 30 
the subjects. However, the blood mask reveals a small amount of unexcited blood in ROI 2 for 31 
one subject (Supporting information - Fig. S3). The excited slice is not thick enough to cover the 32 
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entire blood from this highly curved MCA. Considering the actual slice profile, a larger amount of 1 
blood is expected to have an imperfect flip angle. The inflow of unexcited blood in ROI 3 could be 2 
the cause of the velocity-correlated signal variations that cannot be recovered by FC. Increasing 3 
slice thickness could solve this issue at the cost of higher partial volume effect. 4 
Next, using a single-slice acquisition ensured that the magnetization of inflowing blood was in 5 
a fully relaxed state. Multi-slice acquisition could cause additional blood T1 effects by exciting 6 
upstream blood; such effect would also be correlated with blood velocity.11 This can well be the 7 
case for MCA measurements with full brain coverage. This effect can be avoided by considering 8 
the transit time of blood in the vessels upstream when choosing the number of slices prior to the 9 
MCA and by careful selection of the slice ordering scheme. 10 
Finally, selection of voxels at the end of the straight part of the M1-segment can reduce flow-11 
related effects. Indeed, flow effects are mainly of constant-velocity when the infinite cylinder 12 
approximation is valid for the distance traveled by blood during TE. ROI 3 (Fig. 1c) fulfilled this 13 
condition for four out of five subjects with MCA measurements. Signal variations could not be 14 
decreased in regions where inflowing blood was not excited (ROI 1) or when inflow of excited 15 
blood traveling through vessel curvature are expected to cause higher order flow effects (ROI 2 16 
and 4). In a typical DSC experiment, automatic or manual AIF voxel selection does not rely on 17 
TOF data or ECG trigger delay measurements. In this case, the ideal voxels to reduce flow-related 18 
effects with FC can be identified as voxels with increased dynamic SNR for the intravascular FC 19 
signal that are located three quarters along the M1-segment of the MCA. Fewer voxels are 20 
available for AIF measurements in the ICA perpendicular to the imaging slice. Unfortunately, 21 
careful voxel selection cannot account for inflow and higher order flow effects that may still occur. 22 
In such a case, careful placement of the slice upstream of a straight section of the ICA and 23 
perpendicular to the vessel should help reduce these effects. 24 
Non-FC signal was positively correlated (CORR > 0) with velocity in the ICA for one subject 25 
(Fig. 5c). Accordingly, RSNR was lower than 1 for this subject (Fig. 5a). Flow-induced dephasing 26 
always causes a negative correlation with velocity and therefore cannot have caused this positive 27 
correlation. Inflow effects in the ICA could be the cause of this observation. Following this idea, 28 
inter-individual differences of the arterial physiology may explain the variable level to which RSNR 29 
can be increased by FC (Fig. 5). Indeed, we have shown for MCA that FC fails for a subject with 30 
increased vessel curvature (Supporting information - Fig. S3) where no voxel allows for blood 31 
inflow from a straight segment upstream. This could also be true for a curved ICA downstream of 32 
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the excited slice. Also, it is known that flow effects in SS-EPI will have a strong variation with 1 
vessel orientation relative to Gp.8 2 
Altogether, our results provide additional insights on whether the AIF should be measured 3 
inside or outside the MCA. Simulations by others have shown that intravascular AIF measurement 4 
could be optimal for the short TE of multi-echo EPI sequences to avoid blood signal saturation 5 
during bolus passage.5 However, these simulations did not consider SNR degradation by pulsatile 6 
blood flow effects. Our results show that FC partially recovers these effects but that careful slice 7 
placement over the MCA is required. This might not be possible for routine DSC experiments 8 
without reference TOF data or when multi-slice coverage is already constrained by FOV 9 
requirements. Conversely, no pulsatile flow dependent noise was found for the tissues near the 10 
arteries. AIF measurement in the tissues surrounding the MCA provides high SNR dynamic signal 11 
for relative AIF measurement. 12 
The signal magnitude and phase trigger delay variations found for the ICA is consistent with 13 
previously reported findings for the baboon aorta.12 This previous work reported results for a FC 14 
SS-EPI sequence where the FC was restricted to the slice selective gradient (Gs). To minimize 15 
the trigger delay dependent signal variations, R-wave triggered acquisition during the low velocity 16 
diastole was proposed for intravascular AIF measurement. The TR would thus be continually 17 
adjusted to match the slightly variable cardiac cycle period, which changes the T1-weighting 18 
throughout the experiment. This would cause a variation of CA extravasation effects and is not 19 
practical for brain tumor imaging. Some of these uncorrected variations might be caused by 20 
uncompensated flow in the slice plane. In our study, the ICAs were misaligned with Gs by (11±7)° 21 
providing a transverse component of flow that is FC by in-slice motion correction (Gf and Gp) 22 
additionally to Gs. For the ICA, residual flow-related noise is small compared to other noise 23 
sources after FC. The angulation and geometry of the abdominal aorta were not reported in the 24 
baboon measurements.12 The relative improvement of FC in all directions compared to a Gs–only 25 
FC is unknown for the ICA. A first level of approximation detailed in Section D of the Supporting 26 
Information suggests that FC in all directions is superior for poorly aligned ICA; FC recovers AIF 27 
concentration variations of up to 10% of the peak concentration caused by the transverse 28 
component of flow.  29 
Perfusion experiment 30 
Signal-time curves are affected by noise caused by the variable blood velocity thereby 31 
degrading the intravascular AIF measurement in perfusion experiments. Constant-velocity flow 32 
effects directly affect phase-based AIF measurements. Points with largest deviations are 33 
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associated with frames measured at peak velocity (Fig. 6). FC efficiently reduces these 1 
concentration variations. Visible noise reduction can be appreciated for seven out of ten FC AIFs.  2 
CBF and CBV changes caused by FC are reported, but it is not clear whether these changes 3 
increased the accuracy of the perfusion values as the true values are unknown. Nevertheless, 4 
our methodology reduces noise in intravascular signal which is expected to improve the shape 5 
and precision of the AIF, and to directly influence the quality of perfusion maps.3,13 Flow induced 6 
signal variations consisted of a drop of signal phase at peak blood velocity. This results in lower 7 
average AIF concentrations for non-FC data thus a lower area under the AIF curves. This explains 8 
the decrease of CBV with FC observed for most subjects (Table 1). The effect of FC on CBF is 9 
more complex. It will depend on how flow effects change the shape of the AIF first pass and how 10 
these changes translate through the regularized deconvolution required for CBF calculation. In 11 
addition, the drop of AIF concentration caused by peak flow effects occurs during random time 12 
frames. We note an increase of CBF for two out of three subjects (Table 1) for whom flow effects 13 
occur during the first pass (Fig. 6a,b,c,d,e,f).  14 
Major differences in the fitted spiral calibration curve from the PVCM were found for two AIFs 15 
with either higher (Fig. 6j) or truncated (Fig. 6h) peak AIF for non-FC data. Higher non-FC AIF 16 
peak is the cause of major CBF and CBV increases reported in Table 1 (underlined data). The 17 
PVCM differences could be attributed to the additional noise in non-FC complex signal. The 18 
PVCM relies on the magnitude and phase of the signal; both of which are reduced by flow effects 19 
at peak velocity. This could result in PVCM failure for non-FC data. However, other limitations 20 
reduced the performance of PVCM in this study and could be responsible for differences in the 21 
fitted calibration curves. First, SS-EPI sequences are sensitive to the signal displacement induced 22 
by magnetic field changes during CA passage.19 With our SS-EPI sequence bandwidth of 53.2 23 
Hz/pixel, we expect a displacement of 1 pixel at the peak arterial concentration of 4 mM. This shift 24 
might limit the performance of the PVCM algorithm in correcting the AIF. Next, PVCM relies on 25 
the approximation that the ICA is aligned with B0. For our experiment, the angle between the ICA 26 
and B0 was (10±6)°. This allows minor CA susceptibility effects outside the vessel that can reduce 27 
the efficiency of PVCM. Last, concentration calibration curves for ICA AIF relied on R2∗  relaxivity17 28 
and molar susceptibility7 taken from literature for Gd-DPTA. These values could differ for the Gd-29 
DO3A-butrol used in this study. These constants change the shape of the fitted calibration curve 30 
in the PVCM procedure, which could affect the measured tissue signal contribution, and scale the 31 
phase-based AIF. 32 
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Absolute estimates of gray matter CBF for our subjects are within the range reported at 3T 1 
but our CBV values are lower.2 The ROIs were derived automatically from GM and WM 2 
segmentation and were thus user-independent. A drawback is the inclusion of all voxels 3 
regardless of their perfusion variations, their proximity to major blood vessels, or other 4 
surrounding tissues; this results in a high SD for CBF and CBV in Table 1. GM CBV would be 5 
increased if one manually delineated ROIs to exclude voxels with apparent partial volume effects 6 
with surrounding WM. 7 
Other sequences 8 
This work focused on pulsatile flow and inflow effects specifically for 2D SS-EPI DSC 9 
sequences. Such effects are to be considered for intravascular AIF measurements with other 10 
dynamic sequences.  11 
Multi-echo single-shot spiral-out sequences20 are expected to be robust to flow effects 12 
because their k-space trajectory preserves the properties that provide flow immunity reported for 13 
multi-shot spiral-out imaging.8 Multi-shot EPI (MS-EPI) sequences are known to be sensitive to 14 
flow effects with major distortions and ghosting.8 The fast k-space sampling of 2D MS-EPI 15 
sequences might lead to important velocity variations between k-space time frames, hence to 16 
pulsatile signal variations. However, if the MS-EPI k-space is fully sampled over a full cardiac 17 
cycle, this effect might appear as a constant blood signal offset where each time frame averages 18 
the cardiac cycle velocity variations. This condition should be met for 3D MS-EPI sequences.  19 
For DCE-MRI sequences, the inflow effects have previously been studied.10 However, the 20 
incidence of flow effects and the pulsatile blood flow of the cardiac cycle were not considered. 21 
Flow effects are known to cause signal displacement in SPGR sequences such as in typical DCE 22 
sequences.9 For pulsatile flow in 3D DCE sequences, the k-space is filled during the whole 23 
dynamic scan time covering a wide range of velocities. Based on our simulations, the flow-induced 24 
signal displacement remains constant throughout the dynamic frames and is not a major source 25 
of signal variation (Supporting information - Fig. S4). This constant signal displacement partly 26 
overlaps with the blood signal and surrounding tissue and increases the partial volume effect. It 27 
can also lead to misalignment of the arterial signal with the initial blood T1 map. The signal 28 
displacement might differ between DCE data and T1 map if another sequence type is used or if 29 
gradient echo sequence parameters such as bandwidth and resolution are not identical. 30 
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Conclusion 1 
In summary, this study demonstrated the performance of a methodology based on FC to 2 
improve the SNR of intravascular AIFs. For intravascular AIF measurement in the MCA, the 3 
methodology includes FC, a careful slice placement and voxel selection at the end of the straight 4 
portion of the M1-segment. The reduced noise in FC signal magnitude and phase increases the 5 
precision of PVCM for absolute AIF measurement in the ICA. This could help further improve the 6 
reproducibility of quantitative perfusion measurements. 7 
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Figures 1 
 2 
FIG. 1. DSC sequence diagram with slice and ROI placement for measuring arterial blood signal. 3 
(a) Dual-echo single-shot EPI FC and non-FC sequence diagram. (b) Arterial blood mask derived 4 
from TOF sequence (yellow/red) with DSC slice position for MCA and ICA (blue boxes). Blood 5 
mask within the excited slice is shown in yellow. Initial TOF images allow for the positioning of the 6 
5 mm slice during the acquisition protocol. The blood mask in the left and right M1-segment of 7 
the MCA is completely included within the excited slice. The black lines are the linear regression 8 
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of the straight part of each vessel used to measure the vessel orientation with encoding gradients 1 
(Gf, Gp, Gs) and B0. The enlarged sections of the MCA and the ICA are annotated with gray and 2 
black arrows to show the expected length of inflow in systole and diastole, respectively. For 3 
example, the inflow effect extends for 5 mm (diastole) to 8 mm (systole) with the MCA based on 4 
the first echo TE (14 ms) and blood velocities (33 to 59 cm/s from subject data). ROIs of the 5 
arteries are defined in the DSC images (dashed boxes in (c) MCA and (d) ICA first echo DSC 6 
images). Reporting these ROIs on the TOF arterial blood mask (b), one can appreciate the extent 7 
of blood inflow and vessel curvature expected for each ROI.  8 
  9 
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1 
FIG. 2. Sorting of the dynamic frames by trigger delay. (a) Unsorted signal magnitude-time curve 2 
from a voxel of MCA ROI 3 (Fig. 1c) where the even frames are non-FC and odd frames are FC. 3 
(b) Signal magnitude from (a) sorted by associated trigger delays. SNR and correlation between 4 
signal and velocity (CORR) measured for each curve are shown on this panel. (c) An example of 5 
the trigger delay measurement for the first four dynamic frames from ECG R-peak and acquisition 6 
timestamps (FC and non-FC) that are logged by the MR scanner. The measured MCA blood flow 7 
velocity (dashed gray line) was added to enable direct comparison.  8 
  9 
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 1 
FIG. 3. Dynamic first echo signal sorted by trigger delay for each ROI in the MCA (Fig. 1c) for FC 2 
and non-FC SS-EPI sequences with measured blood flow velocity (dashed curve). SNR and 3 
correlation between signal and velocity (CORR) are indicated for each ROI. Non-FC signal 4 
variation is highly correlated with blood flow velocity in all sections of the MCA. FC increases the 5 
SNR and reduces the absolute correlation mostly for ROI 3. This region corresponds to the last 6 
section of the straight part of the MCA (see Fig. 1b). FC is effective in this region because flow 7 
effects are mainly due to constant-velocity, i.e. the blood inflow between excitation and 8 
measurement comes from upstream excited blood flowing in a straight line.  9 
  10 
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 1 
 2 
FIG. 5. Effect of FC on SS-EPI (a) SNR ratio (RSNR), (b) phase SD ratio (RSD), and (c) correlation 3 
between signal and flow velocity (CORR). These metrics are compiled for all subjects MCA (N=5) 4 
and ICA (N=6). ICA-M and ICA-P indicate the metrics calculated for ICA signal magnitude and 5 
phase, respectively. p-values are shown for all datasets.  6 
  7 
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 1 
FIG. 6. Absolute quantification of the right and left ICA AIFs for all subjects. Right (a,c,e,g,i) and 2 
left (b,d,f,h,j) partial volume corrected AIFs are displayed for non-FC and FC frames. Subject 3 
motion is responsible for the concentration shifts observed at 85 s for subject 5 AIFs (i,j). PVCM 4 
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differences caused an increased shift for the left FC AIF (j). Peak velocity AIF points (open circles 1 
and squares) are data points acquired within a trigger delay of 100-200 ms. 2 
  3 
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 1 
FIG. 7. Detailed comparison of non-FC and FC partial volume correction for cases with (a,b,e) 2 
similar or (c,d,f) different fitted calibration curves. (a-d) Detailed PVCM for non-FC and FC 3 
average signal over the ICA. The dots represent the MR signal in the complex plane for all time 4 
frames. CA calibration curve spiral (red line), first pass time frames (black dots), and constant 5 
tissue signal (blue cross) are shown in the figure. (e,f) partial volume corrected AIF are displayed 6 
for non-FC and FC frames. Subject motion is responsible for the concentration shifts observed at 7 
85 s for subject 5 AIFs (f). PVCM differences cause an increased shift for the FC AIF (red). Peak 8 
velocity AIF points (open circles and squares) are data points acquired within a trigger delay of 9 
100-200 ms.  10 
  11 
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 1 
FIG. 8. (a) CBF and (c) CBV perfusion maps for non-FC and FC data with the AIFs from the left 2 
ICA in Fig. 6f. Voxel by voxel comparison of (b) CBF and (d) CBV highlights the effect of FC on 3 
perfusion metrics. The fitted slopes over (b) and under (d) the line of equality indicate that FC 4 
increases CBF and decreases CBV for this subject.5 
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Table 1. Mean CBF and CBV over gray matter (GM) and white matter (WM) ROIs and percent 1 
differences of the voxel by voxel comparison (DFC) for the non-FC and FC perfusion experiments 2 
measured for the right and left AIF of all subjects. AIFs with major PVCM changes are underlined. 3 
Subjects with significant increased CBF and decreased CBV in the voxel by voxel comparison 4 
are highlighted in bold. DFC are considered significant when their 95% confidence interval (mean 5 
± SD) excludes 0%. Nonsignificant DFC are italicized. 6 
    GM WM DFC (%) 
    non-FC FC non-FC FC 
CBF (mL/100g min), mean (SD)         
Subject 1, Right AIF 59 (47) 65 (53) 39 (56) 40 (55) 1.2 (1.9) 
 Left AIF 66 (53) 68 (57) 43 (65) 42 (59) -8.1 (2.0) 
Subject 2, Right AIF 66 (57) 76 (82) 24 (33) 26 (48) 24.6 (2.3) 
 Left AIF 77 (67) 103 (105) 28 (39) 35 (55) 36.4 (2.4) 
Subject 3, Right AIF 59 (48) 71 (61) 24 (20) 29 (26) 17.6 (2.3) 
 Left AIF 64 (55) 74 (62) 26 (22) 31 (27) 9.7 (2.0) 
Subject 4, Right AIF 106 (84) 102 (83) 37 (32) 35 (29) -19.3 (1.8) 
 Left AIF 69 (52) 132 (106) 24 (19) 46 (37) 91.6 (3.1) 
CBV (mL/100g), mean (SD)          
Subject 1, Right AIF 3.2 (2.7) 3.1 (2.6) 2.1 (2.0) 2.1 (2.1) -3.1 (1.0) 
 Left AIF 3.4 (2.9) 3.3 (2.8) 2.3 (2.2) 2.2 (2.2) -4.3 (1.0) 
Subject 2, Right AIF 3.7 (4.1) 3.3 (3.7) 1.8 (2.0) 1.6 (1.8) -13.7 (1.2) 
 Left AIF 3.6 (4.0) 3.8 (4.2) 1.7 (1.9) 1.9 (2.1) 1.3 (1.5) 
Subject 3, Right AIF 4.2 (3.8) 3.6 (3.3) 1.9 (1.7) 1.7 (1.5) -8.5 (2.4) 
 Left AIF 3.9 (3.6) 3.4 (3.1) 1.8 (1.6) 1.6 (1.4) -8.9 (2.3) 
Subject 4, Right AIF 4.5 (3.4) 4.4 (3.5) 2.4 (1.8) 2.3 (1.7) -4.2 (1.0) 
 Left AIF 3.6 (2.7) 6.0 (4.7) 1.9 (1.4) 3.2 (2.3) 64.8 (1.7) 
 7 
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Supporting information 1 
A. Flow effect simulations for the SS-EPI sequence 2 
Flow effects were simulated with an infinite tube model with constant-velocity parabolic flow 3 
based on the velocity k-space formalism.1 The effects of constant-velocity flow are the only source 4 
of signal variation considered in the simulation. T1 relaxation, T2∗ relaxation, higher order flow 5 
effects, partial volume effects and inflow effects were neglected. Our implementation of the 6 
velocity k-space formalism was validated by reproducing the results of Nishimura et al.8 The 7 
scanner SS-EPI sequence waveform was imported into the simulation framework. Default EPI 8 
ramp sampling was removed from the sequence to allow Cartesian sampling of k-space. The tube 9 
simulation parameters were chosen to match the geometry and flow velocity of the MCA (diameter 10 
of 3 mm, pulsatile flow velocity data from one subject, arterial angulation at 45° with the phase 11 
encoding gradient (Gp)). 12 
Fig. S1a shows the simulated image of an infinite tube with constant velocity parabolic flow 13 
for the SS-EPI sequence. Simulations were repeated for representative input velocities for 15 14 
phases of the cardiac cycle. The resulting signal magnitude and phase are plotted against trigger 15 
delay for the non-FC and FC sequences (Fig. S1bc). For the standard non-FC sequence, the 16 
signal magnitude is decreased by as much as 20% and the signal phase is increased by 30° when 17 
the blood velocity is maximum. These variations result from the changing constant-velocity flow 18 
effect associated with pulsatile velocity. First-order flow compensation (FC) for the center of the 19 
SS-EPI echo train partially recovers these variations. 20 
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B. SS-EPI with a 30⁰ flip angle 1 
The RSNR, RSD, and correlation metrics for MCA ROI 3 and ICA were calculated for every 2 
subject that was scanned with the 30° flip angle sequence (Fig. S2). With limited tissue saturation 3 
for this reduced flip angle, the blood signal was not hyperintense on these datasets. Thus the ROI 4 
definition could not rely on voxels with high signal values. We selected voxel following the vessel 5 
anatomy and showing maximal velocity correlated signal variations for the non-FC dataset. This 6 
is expected to select the voxels with maximal blood signal content because these velocity 7 
correlated signal variations matched the high blood signal intensity on our previous experiment 8 
with the 90⁰ flip angle. However, the flow effects are maximized by this voxel selection scheme 9 
and could lead to an overestimation of the effect of FC shown in Fig. S2.  10 
The data of Fig. 5 used ROI defined from the hyperintense blood signal at 90° flip angle 11 
and should be a more objective representation of FC effects. Both figures show similar FC effects, 12 
with reduced sample size and p-values for Fig. S2. 13 
 14 
Supporting Information FIG. S2. Effect of FC on SS-EPI with a 30° flip angle (a) SNR ratio 15 
(RSNR), (b) phase SD ratio (RSD), and (c) correlation between signal and flow velocity (CORR). 16 
These metrics are compiled for all subjects MCA (N=4) and ICA (N=5). ICA-M and ICA-P indicate 17 
the metrics calculated for ICA signal magnitude and phase, respectively. p-values are shown for 18 
all datasets. 19 
  20 
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D. Flow effect simulations for the SS-EPI sequence for poorly aligned ICA 1 
Realistic flow effect simulations for the ICA require a complex model with finite excitation 2 
length limited by the slice profile. The flow effect simulations of the infinite tube shown in 3 
Supporting Information S1 are not a realistic representation of an artery that crosses the slice 4 
plane. Nevertheless, we used this model as a first level of approximation to investigate the 5 
magnitude of transverse flow effect for a misaligned ICA.  6 
To do so, the projection of the ICA in the transverse plane is approximated as an infinite 7 
tube with parabolic flow. For an  ICA aligned with Gs at 16° (the top 20% misaligned ICA in our 8 
study are over 16°), the magnitude of the transverse velocity reaches over 30% of the total 9 
velocity. With ICA pulsatile velocities ranging from 30 to 80 cm/s, this corresponds to an in-plane 10 
velocity variation of 9 to 24 cm/s.  11 
The simulated non-FC inplane flow effects were small for signal intensity variations (0.95-12 
0.99) and for important phase variations (11-28°). The phase variations represent an error of 0.25 13 
mM for phase based AIF measurements, wich is about 10% of the reported AIF peaks. FC could 14 
recover most of this variation. This simulation suggests that Gf and Gp FC provides an important 15 
noise reduction for the poorly misaligned ICA. 16 
The slice dephasing was not included in this simulation, thus both FC and non-FC curves 17 
would be perfectly flow-compensated for Gs. Our simulation framework cannot estimate the 18 
corresponding noise component to the FC in the Gs direction and would require a more complex 19 
model of a finite excited tube limited by the slice profile. Thus we cannot comment on the relative 20 
improvement of FC in all directions compared to a Gs–only FC, this simulation provides a first 21 
level of approximation limited to the absolute improvement of inplane flow effects by FC in all 22 
directions. 23 
  24 
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E. Flow effect simulations for the 3D SPGR sequence 1 
A dual echo 3D SPGR sequence waveform was imported from the scanner into the simulation 2 
framework with and without flow compensation. The sequence diagram is shown in Fig. S4a for 3 
the FC gradients waveforms. The sequence had the additional following parameters: FOV = 220 4 
x 158 x 90 mm3; spatial resolution = 1.7 x 1.7 x 3 mm3; time resolution = 33 s; Profile order: 5 
CENTRA. Parallel imaging acceleration was removed from the sequence to allow Cartesian 6 
sampling of k-space. 7 
The simulation framework described in Supporting information S1 was modified for 3D 8 
acquisition. In this case, the dynamic frame k-space is sampled over several cardiac cycle. The 9 
specific velocity of each line of k-space was found with sequence timings. To do so, the subject 10 
velocity profile was first sub-sampled with 16 specific velocities (Fig. S4b). Then, the constant-11 
velocity 3D k-space was simulated for each of these velocities with the parabolic flow infinite tube 12 
model. Next, the frame k-space with pulsatile velocity was assembled using data from these 13 
constant-velocity k-spaces, where sequence timings and profile ordering were compared to a 14 
constant cardiac cycle to attribute the velocities in the frame phase-encoding plane (Fig. S4c). 15 
This was repeated for 16 frames with different starting trigger delays in the cardiac cycle. The 16 
signal magnitude and phase from the voxel with the highest magnitude in the centered slice (Fig. 17 
S4d – voxel identified with the dot) is reported for the 16 frames (Fig. S4ef).  18 
The signal loss from flow effects is constant and induced by the displacement in the kz phase 19 
encoding direction that was not accounted for by voxel selection. This effect would result in a 20 
constant SNR loss and increased PVE.  21 

